APA (7th ed.) Citation

Chemaitelly, H., Ayoub, H. H., Coyle, P., Tang, P., Hasan, M. R., Yassine, H. M., . . . Al-Khal, A. (2025). Effectiveness of ChAdOx1 nCoV-19 (Vaxzevria) primary series vaccine against SARS-CoV-2 beta and delta variants: A nationwide study. BMC Infectious Diseases, 25(1), 1. https://doi.org/10.1186/s12879-025-11410-7

Chicago Style (17th ed.) Citation

Chemaitelly, Hiam, et al. "Effectiveness of ChAdOx1 NCoV-19 (Vaxzevria) Primary Series Vaccine Against SARS-CoV-2 Beta and Delta Variants: A Nationwide Study." BMC Infectious Diseases 25, no. 1 (2025): 1. https://doi.org/10.1186/s12879-025-11410-7.

MLA (9th ed.) Citation

Chemaitelly, Hiam, et al. "Effectiveness of ChAdOx1 NCoV-19 (Vaxzevria) Primary Series Vaccine Against SARS-CoV-2 Beta and Delta Variants: A Nationwide Study." BMC Infectious Diseases, vol. 25, no. 1, 2025, p. 1, https://doi.org/10.1186/s12879-025-11410-7.